Ipsilateral Prominent Thalamostriate Vein on Susceptibility-Weighted Imaging Predicts Poor Outcome after Intravenous Thrombolysis in Acute Ischemic Stroke

REFERENCES

1. 1.↵
   2. Chen CY,
   3. Chen CI,
   4. Tsai FY, et al

   . Prominent vessel sign on susceptibility-weighted imaging in acute stroke: prediction of infarct growth and clinical outcome. PLoS One 2015;10:e0131118 doi:10.1371/journal.pone.0131118 pmid:26110628

   CrossRefPubMed
2. 2.↵
   2. Baik SK,
   3. Choi W,
   4. Oh SJ, et al

   . Change in cortical vessel signs on susceptibility-weighted images after full recanalization in hyperacute ischemic stroke. Cerebrovasc Dis 2012;34:206–12 doi:10.1159/000342148 pmid:23006622

   CrossRefPubMed
3. 3.↵
   2. Sun W,
   3. Liu W,
   4. Zhang Z, et al

   . Asymmetrical cortical vessel sign on susceptibility-weighted imaging: a novel imaging marker for early neurological deterioration and unfavorable prognosis. Eur J Neurol 2014;21:1411–18 doi:10.1111/ene.12510 pmid:25040846

   CrossRefPubMed
4. 4.↵
   2. Zaitsu Y,
   3. Kudo K,
   4. Terae S, et al

   . Mapping of cerebral oxygen extraction fraction changes with susceptibility-weighted phase imaging. Radiology 2011;261:930–36 doi:10.1148/radiol.11102416 pmid:22031711

   CrossRefPubMed
5. 5.↵
   2. Santhosh K,
   3. Kesavadas C,
   4. Thomas B, et al

   . Susceptibility weighted imaging: a new tool in magnetic resonance imaging of stroke. Clin Radiol 2009;64:74–83 doi:10.1016/j.crad.2008.04.022 pmid:19070701

   CrossRefPubMed
6. 6.↵
   2. Robertson CA,
   3. McCabe C,
   4. Gallagher L, et al

   . Stroke penumbra defined by an MRI-based oxygen challenge technique, 1: validation using [14C]2-deoxyglucose autoradiography. J Cereb Blood Flow Metab 2011;31:1778–87 doi:10.1038/jcbfm.2011.66 pmid:21559032

   CrossRefPubMed
7. 7.↵
   2. De Crespigny AJ,
   3. Wendland MF,
   4. Derugin N, et al

   . Real-time observation of transient focal ischemia and hyperemia in cat brain. Magn Reson Med 1992;27:391–97 doi:10.1002/mrm.1910270220 pmid:1461120

   CrossRefPubMed
8. 8.↵
   2. Fujioka M,
   3. Okuchi K,
   4. Iwamura A, et al

   . A mismatch between the abnormalities in diffusion- and susceptibility-weighted magnetic resonance imaging may represent an acute ischemic penumbra with misery perfusion. J Stroke Cerebrovasc Dis 2013;22:1428–31 doi:10.1016/j.jstrokecerebrovasdis.2012.12.009 pmid:23410687

   CrossRefPubMed
9. 9.↵
   2. Huang P,
   3. Chen CH,
   4. Lin WC, et al

   . Clinical applications of susceptibility weighted imaging in patients with major stroke. J Neurol 2012;259:1426–32 doi:10.1007/s00415-011-6369-2 pmid:22186853

   CrossRefPubMed
10. 10.↵
    2. Doshi H,
    3. Wiseman N,
    4. Liu J, et al

    . Cerebral hemodynamic changes of mild traumatic brain injury at the acute stage. PLoS One 2015;10:e0118061 doi:10.1371/journal.pone.0118061 pmid:25659079

    CrossRefPubMed
11. 11.↵
    2. Purushotham A,
    3. Campbell BC,
    4. Straka M, et al

    . Apparent diffusion coefficient threshold for delineation of ischemic core. Int J Stroke 2015;10:348–53 doi:10.1111/ijs.12068 pmid:23802548

    CrossRefPubMed
12. 12.↵
    2. Zhang S,
    3. Tang H,
    4. Yu YN, et al

    . Optimal magnetic resonance perfusion thresholds identifying ischemic penumbra and infarct core: a Chinese population-based study. CNS Neurosci Ther 2015;21:289–95 doi:10.1111/cns.12367 pmid:25476071

    CrossRefPubMed
13. 13.↵
    2. Jung S,
    3. Gilgen M,
    4. Slotboom J, et al

    . Factors that determine penumbral tissue loss in acute ischaemic stroke. Brain 2013;136(pt 12):3554–60 doi:10.1093/brain/awt246 pmid:24065722

    Abstract/FREE Full Text
14. 14.↵
    2. DeLong MR,
    3. Alexander GE,
    4. Mitchell SJ, et al

    . The contribution of basal ganglia to limb control. Prog Brain Res 1986;64:161–74 doi:10.1016/S0079-6123(08)63411-1 pmid:3088671

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Mink JW,
    3. Thach WT

    . Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. J Neurophysiol 1991;65:330–51 pmid:2016644

    Abstract/FREE Full Text
16. 16.↵
    2. Wichmann T,
    3. DeLong MR

    . Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996;6:751–58 doi:10.1016/S0959-4388(96)80024-9 pmid:9000030

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Cheng B,
    3. Forkert ND,
    4. Zavaglia M, et al

    . Influence of stroke infarct location on functional outcome measured by the modified Rankin scale. Stroke 2014;45:1695–702 doi:10.1161/STROKEAHA.114.005152 pmid:24781084

    Abstract/FREE Full Text
18. 18.↵
    2. Hermier M,
    3. Nighoghossian N,
    4. Derex L, et al

    . Hypointense transcerebral veins at T2*-weighted MRI: a marker of hemorrhagic transformation risk in patients treated with intravenous tissue plasminogen activator. J Cereb Blood Flow Metab 2003;23:1362–70 doi:10.1371/journal.pone.0120801 pmid:14600444

    CrossRefPubMed
19. 19.↵
    2. Meoded A,
    3. Poretti A,
    4. Benson JE, et al

    . Evaluation of the ischemic penumbra focusing on the venous drainage: the role of susceptibility weighted imaging (SWI) in pediatric ischemic cerebral stroke. J Neuroradiol 2014;41:108–16 doi:10.1016/j.neurad.2013.04.002 pmid:23827386

    CrossRefPubMed
20. 20.↵
    2. Mucke J,
    3. Möhlenbruch M,
    4. Kickingereder P, et al

    . Asymmetry of deep medullary veins on susceptibility weighted MRI in patients with acute MCA stroke is associated with poor outcome. PLoS One 2015;10: e0120801 doi:10.1371/journal.pone.0120801 pmid:25849958

    CrossRefPubMed
21. 21.↵
    2. Phan TG,
    3. Wright PM,
    4. Markus R, et al

    . Salvaging the ischaemic penumbra: more than just reperfusion? Clin Exp Pharmacol Physiol 2002;29:1–10 doi:10.1046/j.1440-1681.2002.03609.x pmid:11917903

    CrossRefPubMed
22. 22.↵
    2. Oh MY,
    3. Ko SB,
    4. Kim CK, et al

    . Abstract 13: Asymmetry of deep medullary veins in susceptibility weighted imaging is associated with poor collaterals in patients with acute ischemic stroke. Stroke 2013;44(suppl 1):A13
23. 23.↵
    2. Verma RK,
    3. Hsieh K,
    4. Gratz PP, et al

    . Leptomeningeal collateralization in acute ischemic stroke: impact on prominent cortical veins in susceptibility-weighted imaging. Eur J Radiol 2014;83:1448–54 doi:10.1016/j.ejrad.2014.05.001 pmid:24882785

    CrossRefPubMed
24. 24.↵
    2. Parthasarathy R,
    3. Sohn SI,
    4. Jeerakathil T, et al

    . A combined arterial and venous grading scale to predict outcome in anterior circulation ischemic stroke. J Neuroimaging 2015;25:969–77 doi:10.1111/jon.12260 pmid:26082023

    CrossRefPubMed
25. 25.↵
    2. Bang OY,
    3. Saver JL,
    4. Buck BH, et al

    ; UCLA Collateral Investigators. Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2008;79:625–29 pmid:18077482

    Abstract/FREE Full Text
26. 26.↵
    2. Zhou Y,
    3. Wang Y,
    4. Wang J, et al

    . Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol 2014;115:25–44 doi:10.1016/j.pneurobio.2013.11.003 pmid:24291544

    CrossRefPubMed
27. 27.↵
    2. Schwarzmaier SM,
    3. Kim SW,
    4. Trabold R, et al

    . Temporal profile of thrombogenesis in the cerebral microcirculation after traumatic brain injury in mice. J Neurotrauma 2010;27:121–30 doi:10.1089/neu.2009.1114 pmid:19803784

    CrossRefPubMed
28. 28.↵
    2. Li Q,
    3. Khatibi N,
    4. Zhang JH

    . Vascular neural network: the importance of vein drainage in stroke. Transl Stroke Res 2014;5:163–66 doi:10.1007/s12975-014-0335-0 pmid:24563018

    CrossRefPubMed
29. 29.↵
    2. Berkhemer OA,
    3. Fransen PS,
    4. Beumer D, et al

    . A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20 doi:10.1056/NEJMoa1411587 pmid:25517348

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Goyal M,
    3. Demchuk AM,
    4. Menon BK, et al

    ; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30 doi:10.1056/NEJMoa1414905 pmid:25671798

    CrossRefPubMed